Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statement of Stockholders' Equity (Unaudited)

v3.19.1
Consolidated Statement of Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Noncontrolling Interest [Member]
Total
Balance (in shares) at Dec. 31, 2017 8,110,332          
Balance at Dec. 31, 2017 $ 162,207 $ 331,128,787 $ (319,908,968) $ (2,396) $ 668,700 $ 12,048,330
Issued restricted stock (in shares) 10,000          
Issued restricted stock $ 200 200
Stock compensation expense 137,964 137,964
Net income (loss) (6,737,953) (9) (6,737,962)
Unrealized gain (loss) on available-for-sale securities (176) (176)
Total comprehensive income (loss) (6,738,138)
Impact of adoption of ASC Topic 606 at Dec. 31, 2017 (700,000) (700,000)
Issued stock in payment of employee bonuses (in shares) 22,920          
Issued stock in payment of employee bonuses $ 458 164,563 $ 165,021
Issued stock to 401(k) plan (in shares) 4,734         4,734
Issued stock to 401(k) plan $ 95 35,885 $ 35,980
Balance (in shares) at Mar. 31, 2018 8,147,986          
Balance at Mar. 31, 2018 $ 162,960 331,467,199 (327,346,921) (2,572) 668,691 4,949,357
Balance (in shares) at Dec. 31, 2018 10,019,535          
Balance at Dec. 31, 2018 $ 200,391 338,265,383 (336,722,905) (730) 668,321 2,410,460
Issued restricted stock (in shares) 15,000          
Issued restricted stock $ 300 300
Issued stock pursuant to Stock Purchase Agreement (in shares) 17,857          
Issued stock pursuant to Stock Purchase Agreement $ 357 49,643 50,000
Stock compensation expense 61,978 61,978
Net income (loss) (2,429,049) (12) (2,429,061)
Unrealized gain (loss) on available-for-sale securities 958 958
Total comprehensive income (loss) (2,428,103)
Balance (in shares) at Mar. 31, 2019 10,052,392          
Balance at Mar. 31, 2019 $ 201,048 $ 338,377,004 $ (339,151,954) $ 228 $ 668,309 $ 94,635